Crossmark

The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

Crossref DOI link: https://doi.org/10.1007/s00401-020-02157-3

Published Online: 2020-04-30

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Van der Perren, Anke https://orcid.org/0000-0003-2924-7392
Gelders, Géraldine

Fenyi, Alexis

Bousset, Luc

Brito, Filipa

Peelaerts, Wouter

Van den Haute, Chris

Gentleman, Steve

Melki, Ronald

Baekelandt, Veerle https://orcid.org/0000-0001-8966-2921
Funding

Funding for this research was provided by:

Flemish Parkinson Liga

Fonds Wetenschappelijk Onderzoek (G.0927.14)

Fonds Wetenschappelijk Onderzoek (G080517N)

Fonds Wetenschappelijk Onderzoek (12K0216N)

JPND (SYNACTION-ANR-15-JPWG-0012-03)

Medical Foundation Queen Elisabeth

Centre National de la Recherche Scientifique

Fondation Simone et Cino Del Duca

Fondation Bettencourt-Schueller

Fondation Recherche Médicale (20160334896)

EC Joint Programme on Neurodegenerative Diseases TransPathND (ANR-17-JPCD-0002-02)

EFPIA Innovative Medicines Initiative 2 (IMPRiND grant agreement No 116060)

King Baudouin Foundation (Fund Sophia)
License Information

Text and Data Mining valid from 2020-04-30

Version of Record valid from 2020-04-30
More Information

Article History

Received: 16 December 2019

Revised: 7 April 2020

Accepted: 7 April 2020

First Online: 30 April 2020

Compliance with ethical standards

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below